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Background and Purpose—Direct transportation to a center with facilities for endovascular treatment might be beneficial 
for patients with acute ischemic stroke, but it can also cause harm by delay of intravenous treatment. Our aim was to 
determine the optimal prehospital transportation strategy for individual patients and to assess which factors influence this 
decision.
Methods—We constructed a decision tree model to compare outcome of ischemic stroke patients after transportation to a 
primary stroke center versus a more distant intervention center. The optimal strategy was estimated based on individual 
patient characteristics, geographic location, and workflow times. In the base case scenario, the primary stroke center was 
located at 20 minutes and the intervention center at 45 minutes. Additional sensitivity analyses included an urban scenario 
(10 versus 20 minutes) and a rural scenario (30 versus 90 minutes).
Results—Direct transportation to the intervention center led to better outcomes in the base case scenario when the likelihood 
of a large vessel occlusion as a cause of the ischemic stroke was >33%. With a high likelihood of large vessel occlusion 
(66%, comparable with a Rapid Arterial Occlusion Evaluation score of 5 or above), the benefit of direct transportation 
to the intervention center was 0.10 quality-adjusted life years (=36 days in full health). In the urban scenario, direct 
transportation to an intervention center was beneficial when the risk of large vessel occlusion was 24% or higher. In the 
rural scenario, this threshold was 49%. Other factors influencing the decision included door-to-needle times, door-to-
groin times, and the door-in-door-out time.
Conclusions—The preferred prehospital transportation strategy for suspected stroke patients depends mainly on the 
likelihood of large vessel occlusion, driving times, and in-hospital workflow times. We constructed a robust model that 
combines these characteristics and can be used to personalize prehospital triage, especially in more remote areas.   (Stroke. 
2019;50:313-320. DOI: 10.1161/STROKEAHA.118.022562.)
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Interhospital transfer for endovascular treatment (EVT) of patients with acute ischemic stroke because of an intracra-
nial large vessel occlusion (LVO) is one of the major causes 
of treatment delay.1–5 Delay of EVT is associated with poor 
functional outcome.6,7 Early identification of patients eligible 
for EVT followed by direct transportation to an endovascular-
capable center might reduce transfer-related delay and thereby 
improve outcome. For this purpose, several prehospital stroke 
scales have been developed to identify patients who are at 
high risk of having an intracranial LVO based on their clinical 
symptoms. Currently, there is no evidence on superiority of 
one of these scales and more prospective validation in the pre-
hospital setting is needed to reliable assess their accuracy.8,9
Other factors that might be of importance for the prehos-
pital triage of suspected stroke patients include the prognosis 
of an individual patient and the expected benefit of EVT. 
Especially because of the large majority of ischemic stroke 
patients is not eligible for EVT and only benefits from rapid 
treatment with intravenous thrombolytics (IVT), the harm 
of delaying IVT should be taken into account as well. The 
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time-dependent effect of both treatments requires a tradeoff 
between reducing delay of IVT by transportation to the near-
est primary stroke center and avoiding transfer-related delay 
of EVT by direct transportation to an endovascular-capable 
intervention center.
Our aim was to determine the optimal prehospital transpor-
tation strategy for individual patients with suspected ischemic 
stroke and to assess which factors influence this decision.
Methods
Decision Model
We constructed a decision tree model to compare outcome of 
patients with ischemic stroke after 2 different prehospital strate-
gies: transportation to the nearest primary stroke center versus di-
rect transportation to a more distant intervention center (Figure 1). 
The outcome of each strategy was estimated based on individual 
patient characteristics, geographic location, and treatment times. 
We combined a short-run model including 3 months outcome data 
from randomized controlled trials and a long-run Markov model 
that simulated 40 annual cycles. The benefit of direct transporta-
tion to the intervention center was defined as the average amount 
of quality-adjusted life years (QALYs) gained by this strategy. We 
considered a difference of >0.02 QALYs (=1 week in full health) to 
be clinically relevant.
Our study did not need approval by an ethics committee because 
we did not use individual patient data. Analytic methods and study 
materials that support the findings of this study are available from the 
corresponding author on reasonable request.
Model Parameters
Individual input parameters consisted of age, sex, time since symptom 
onset, likelihood of LVO, driving time from scene to the primary 
stroke center, driving time from scene to the intervention center, and 
driving time between the primary stroke center and the intervention 
center. The base case used in our analyses was a 68-year old man with 
suspected stroke symptoms since 1 hour and an average risk of 30% 
to have an LVO causing the ischemic stroke. The nearest primary 
stroke center in the base case scenario was located at a 20 minutes 
drive by ambulance, while the intervention center was located at 45 
minutes. Driving time between the centers was 35 minutes. Total time 
to treatment was calculated based on the driving times and in-hospital 
workflow characteristics (Tables 1 through 3). These parameters were 
varied in several sensitivity analyses.
Other model parameters were estimated based on previous liter-
ature and expert opinion of 2 neurovascular specialists (Drs Dippel 
and Roozenbeek; Table I in the online-only Data Supplement). The β 
coefficients of treatment effect and time-dependent decline of treat-
ment effect were estimated with an ordinal logistic regression model 
using previously reported outcome distributions of treated patients 
and control patients in different time intervals.6,10 The effect of the 
uncertainty around these estimates was assessed with a probabilistic 
sensitivity analysis.
Likelihood of LVO
We modeled the entire range from 0% to 100% likelihood of hav-
ing an LVO as a cause of the ischemic stroke, and we calculated the 
threshold at which direct transportation to the intervention center 
would be beneficial. The average prevalence of LVO ranges mostly 
between 20% and 40% in different populations of ischemic stroke 
patients,11 but prehospital stroke scales can be used in individual 
patients to distinguish between lower and higher risk. To illustrate 
this, we calculated the likelihood of LVO in case of a positive test 
(positive predictive value) and in case of a negative test (1 minus the 
negative predictive value) for the Los Angeles Motor Scale, the Rapid 
Arterial Occlusion Evaluation, and the 3-Item Stroke Scale using the 
pooled sensitivity and specificity rates reported in a previous meta-
analysis (Table 4).8 In the sensitivity analyses, we used the Rapid 
Arterial Occlusion Evaluation scale for examples of low risk (14%) 
and high risk (66%).
Figure 1. Schematic overview of the model structure. The model starts with the initial decision of transportation to the primary stroke center or to the near-
est endovascular-capable intervention center. The short-run model calculates the probability of every possible pathway and the associated distribution of 
the modified Rankin Scale (mRS) score after 3 mo. It takes into account driving times, in-hospital workflow characteristics, and time-dependent treatment 
effects. In each annual cycle of the following Markov model, patients can remain in the same health state or die. These probabilities are based on the age and 
sex-dependent annual mortality rates, adjusted for previously reported death hazard rate ratios of stroke patients. The decision node is represented with a 
square. The circles represent chance nodes, the circles marked with an M represent Markov models and the triangles represent terminal nodes. EVT indicates 
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Outcome Measures
The primary outcome of the short-run model was the distribution of 
modified Rankin Scale (mRS) scores after 3 months. The mRS is a 
7-point scale to assess functional outcome and disability and ranges 
from 0 (no symptoms) to 6 (death). The outcome distributions of un-
treated ischemic stroke patients with and without an LVO were based 
on the control groups of previously reported randomized clinical trials 
(Figure I in the online-only Data Supplement).10,12 These distributions 
were shifted for different outcomes based on the estimated treatment 
effect. To do so, we first transformed the probabilities of each of the 
baseline mRS scores to the log-odds scale, using the formula log-
odds(p) =log(p/(1−p)). We then adjusted these log-odds for the effect 
of IVT and EVT by adding the β coefficient (=log odds ratio) for the 
treatment effect at time 0 minus the decline in treatment effect over 
time (Tables 5 and 6). The adjusted log-odds were then converted 
back to probabilities using the inverse logit function: p(log-odds) =1/
(1+exp(−log-odds)). This resulted in the adjusted mRS distributions 
for treated patients.
All mRS scores were considered to be separate health states with 
an associated utility score to calculate the average amount of QALYs 
per strategy. This is a commonly used measure to assess both the 
length and the quality of life.13 Utility scores represent the quality of 
life, and range from 1 (perfect quality of life) to 0 (death), or lower 
for states considered worse than death. We used previously reported 
utility scores for ischemic stroke patients: 0.95 for mRS score of 0; 
0.93 for mRS score of 1; 0.83 for mRS score of 2; 0.62 for mRS 
score of 3; 0.42 for mRS score of 4; and 0.11 for mRS score of 5.14 
The average life expectancy was calculated for every mRS category 
with a long-run Markov model that simulated 40 annual cycles. Age 
and sex-dependent annual mortality rates were adjusted for previ-
ously reported death hazard rate ratios of stroke patients (Table I in 
the online-only Data Supplement).15 Life years were discounted with 
3% per year. We calculated the total number of QALYs by multiply-
ing the utility scores of each mRS category with the corresponding 
life expectancy in years.
Model Assumptions
The model was used for scenarios in which the nearest hospital is not 
an intervention center because there has to be decisional uncertainty 
about the optimal transportation strategy. Outcome was modeled for 
patients with ischemic stroke only, disregarding other diagnoses. A 
substantial proportion of all patients suspected of ischemic stroke has 
an intracerebral hemorrhage, a transient ischemic attack or a stroke-
mimic, but we assumed the outcome of these patients to be unrelated 
to the transportation strategy. Because our analyses concerned the 
tradeoff between IVT and EVT, we did not consider patients present-
ing >4.5 hours after onset of symptoms.
We assumed that IVT could be given within 4.5 hours after onset 
of symptoms and EVT within 6 hours after onset. We modeled the 
decrease in treatment effect of IVT and EVT consistently over time 
and similar for all patients. Because large pooled analyses showed no 
significant interaction between age or sex and treatment effect, we 
did not include age- or sex-specific treatment effects in our model.12,16 
The relative treatment effect of IVT was not influenced by stroke 
severity, which implies a smaller absolute treatment effect for patients 
with a more severe stroke. The importance of these model assump-
tions was assessed in several sensitivity analyses.
Sensitivity Analyses
In addition to the base case scenario, we also assessed examples 
of an urban scenario (10 minutes from scene to primary stroke 
center; 20 minutes from scene to intervention center; and 15 min-
utes intercenter driving time) and a more rural scenario (30, 90, and 
75 minutes, respectively). We used a Tornado-analysis to explore 
the relative importance of the model parameters, by varying each 
parameter at a time while the others were held constant. Additional 
sensitivity analyses were performed with: increased workflow 
times in the primary stroke center (Table 2), a female patient, a pa-
tient with contra-indications for IVT, an absent effect of IVT for 
patients with an LVO, and utility weights as defined in a study of 
Chaisinanunkul et al.17
We performed a probabilistic sensitivity analysis using second-
order Monte-Carlo simulations to assess decisional uncertainty 
around the model parameters. This involves running the model 
10 000 times and calculating the optimal transportation strategy 








From scene to primary stroke center 20 10 30
From scene to intervention center 45 20 90
From primary stroke center to 
intervention center
35 15 75
Primary stroke center: the nearest nonendovascular-capable stroke center 
and intervention center: the nearest endovascular-capable stroke center. 
EVT indicates endovascular treatment; and IVT, treatment with intravenous 
thrombolytics.







Door-to-needle time (primary stroke center) 30 60
Door-to-needle time (intervention center) 30 30
Door-in-door-out time (primary stroke center) 60 90
Door-to-groin time (directly admitted) 80 80
Door-to-groin time (transferred) 50 50
Primary stroke center: the nearest nonendovascular-capable stroke center 
and intervention center: the nearest endovascular-capable stroke center.
Table 3. Calculations of Treatment Times in the Model, in Minutes
Treatment Times
Time to IVT (primary stroke center) Time since onset of 
symptoms+driving time from scene 
to primary stroke center+door-
to-needle time in primary stroke 
center
Time to IVT (intervention center) Time since onset of 
symptoms+driving time from scene 
to intervention center+door-to-
needle time in intervention center
Time to EVT (directly admitted) Time since onset of 
symptoms+driving time from scene 
to intervention center+door-to-
groin time for directly admitted 
patients
Time to EVT (transferred) Time since onset of 
symptoms+driving time from scene 
to primary stroke center+door-
in-door-out time+driving time 
from primary stroke center to 
intervention center+door-to-groin 
time for transferred patients
Primary stroke center: the nearest nonendovascular-capable stroke center 
and intervention center: the nearest endovascular-capable stroke center. 
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every single time. In each simulation, the estimates of the model 
parameters were randomly sampled from the prespecified distribu-
tion of each parameter (β, (log)normal or triangular; Table I in the 
online-only Data Supplement). We reported the percentage of simu-
lations in which transportation to the primary stroke center or direct 
transportation to the intervention center was preferred, and the me-
dian benefit of direct transportation to an intervention center with a 
95% credible interval.
We constructed an online tool in which input factors and regional 
workflow times can be adjusted for an individual patient in a spe-
cific scenario. We used R statistical software (version 3.4.4) with the 




Direct transportation to the intervention center was preferred 
for the 68-year-old man in the base case scenario, with a pri-
mary stroke center located at 20 minutes and an intervention 
center at 45 minutes, when the likelihood of LVO was 34% or 
above (Figure 2). When the risk of having an LVO was 66%, 
comparable with a Rapid Arterial Occlusion Evaluation score 
of 5 or more, the benefit of direct transportation to the inter-
vention center was 0.10 QALYs (=36 days). When the risk of 
having an LVO was 14%, comparable with a Rapid Arterial 
Occlusion Evaluation score below 5, transportation to the pri-
mary stroke center was preferred with a difference of 0.03 
QALYs (=11 days).
Sensitivity Analyses
In the urban scenario (10 minutes to the primary stroke center 
and 20 minutes to the intervention center), the threshold for 
direct transportation to the intervention center was lower than 
in the base case scenario (24%; Figure 2). In the rural scenario 
(30 minutes to the primary stroke center and 90 minutes to the 
intervention center), direct transportation to the intervention 
center was only preferred for patients with an LVO likelihood 
of 49% or above.
Other factors that strongly affected the decision 
threshold in the Tornado-analysis were the in-hospital 
workflow characteristics (Figure III in the online-only 
Data Supplement). While remaining the other parameters 
of the base case constant, transportation to the primary 
stroke center was beneficial when the door-to-groin time 
for directly transported patients was above 102 minutes, the 
door-to-groin time for transferred patients was below 28 
minutes, or the door-in-door-out time in the primary stroke 
center was <38 minutes. Age did not influence the preferred 
strategy, although it was important for the general prog-
nosis of individual patients.
In the analysis with increased workflow times in the pri-
mary stroke center, transportation to the intervention center 
was more favorable (Figure IV in the online-only Data 
Supplement). As might be expected, we found that transpor-
tation to the primary stroke center was never preferred for a 
patient with contra-indications for IVT. In all other explora-
tory sensitivity analyses, the decision threshold remained rel-
atively unchanged.
Probabilistic Sensitivity Analysis
The uncertainty around the estimates of the model parameters 
caused little decisional uncertainty in the probabilistic sensi-
tivity analysis (Table II in the online-only Data Supplement). 
When the risk of having an LVO in the base case scenario was 
high, transportation to the intervention center was associated 
with a clinically relevant benefit in 94% of the simulations 
with a median difference of 0.09 QALYs (=33 days in full 
health, 95% credible interval: 0.00–0.20). When the risk of 
having an LVO was low, direct transportation to the interven-
tion center was preferred in only 6% of the simulations, with 
a median difference of −0.03 QALYs (95% credible interval: 
−0.09 to 0.03).
Table 4. Likelihood of LVO Based on Several Prehospital Stroke Scales
Stroke Scale Sensitivity* Specificity*
Prior Probability =20% Prior Probability =30% Prior Probability =40%
PPV 1-NPV PPV 1-NPV PPV 1-NPV
LAMS ≥4 38% 87% 42% 15% 56% 23% 66% 32%
RACE ≥5 67% 85% 53% 9% 66% 14% 75% 21%
3I-ISS ≥4 19% 97% 61% 17% 73% 26% 81% 36%
The different prior probabilities illustrate the prevalence of LVO in different populations of ischemic stroke patients. 3I-SS indicates 3-Item Stroke Scale; LAMS, Los 
Angeles Motor Scale; LVO, large vessel occlusion; NPV, negative predictive value; PPV, positive predictive value; and RACE, Rapid Arterial Occlusion Evaluation.
*Pooled sensitivity and specificity rates as reported previously.8
Table 5. Calculations of Treatment Effect in the Model
Treatment Characteristics
Probability of receiving IVT If treatment is possible within 4.5 
h after onset of symptoms: 55%, 
otherwise: 0%
Probability of early reperfusion If presenting with an LVO and treated 
with IVT: 11%, otherwise: 0%
Probability of receiving EVT If treatment is possible within 6 
h after onset of symptoms: 85%, 
otherwise 0%
Treatment effect IVT (β coefficient)* 0.56 (=odds ratio 1.75) at time 
0, minus 0.0019× time to IVT in 
minutes
Treatment effect EVT (β 
coefficient)*
1.35 (=odds ratio 3.85) at time 
0, minus 0.0026× time to EVT in 
minutes
EVT indicates endovascular treatment; IVT, treatment with intravenous 
thrombolytics; and LVO, large vessel occlusion.
*The time-dependent decrease in treatment effect is illustrated in Figure II in 
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Online Tool
The effect of simultaneous changes in individual patient 
characteristics and regional workflow characteristics on the 
optimal prehospital transportation strategy for individual 
patients can be further explored by using the online tool at 
https://mrpredicts.shinyapps.io/triage/ (Figure 3).
Discussion
Our decision model shows that direct transportation to an in-
tervention center can be beneficial for patients with a high risk 
of having an LVO, but will likely lead to worse outcomes when 
the risk is low, especially in scenarios with longer driving 
times. Combining individual likelihood of LVO and estimated 
driving times on a case-by-case basis could improve prehos-
pital triage decisions, decrease treatment delay and thereby 
improve functional outcome of individual patients. In-hospital 
workflow characteristics such as the door-in-door-out and 
door-to-groin times have a large effect on the optimal strategy 
as well. Our online tool allows individual and regional input to 
inform prehospital triage strategies in different settings.
No single time threshold can be given to optimize triage 
decisions without considering the probability of being eligible 
for EVT, as was described by other models.18–21 As a measure 
for the likelihood of LVO, these models used previously re-
ported cutoffs of one or multiple prehospital stroke scales. 
However, prospective prehospital validation is required to 
assess and compare the accuracy of these scales when used 
by emergency medical services in a broad population of sus-
pected stroke patients.8 The full dependence of these models 
on insufficiently validated prehospital stroke scales limits the 
validity of their results. Therefore, we did not depend our 
model on a specific prehospital stroke scale but assessed the 
entire range from 0% to 100% likelihood of LVO. Several pre-
hospital stroke scales may be used to estimate this likelihood, 
preferably after more extensive validation.
Our study also has some limitations. Decision-analytic 
modeling requires the use of estimated model parameters and 
multiple assumptions. In extensive sensitivity analyses, we 
found no substantial decisional uncertainty. Nevertheless, the 
assumptions we made about the treatment effect of IVT and 
EVT might have influenced our results. We used reported out-
comes and effect sizes of IVT based on studies that did not 
assess LVO status because randomized trials on the effect of 
IVT were performed before the introduction of CT angiog-
raphy as standard of care for acute stroke patients. To calcu-
late a common odds ratio for the decay in effect of IVT, we 
used mRS distributions at different time points provided by a 
pooled analysis from 2004.10 A more recent study with a larger 
sample size only reported odds ratios specific for the cutoff 
of mRS score of 0 to 1,16 which are not valid to use in shift-
analyses of total mRS score. Although the effect of IVT tends 
to diminish with more proximally located occlusions,22,23 we 
included a consistent relative treatment effect of IVT in the 
range of the National Institutes of Health Stroke Scale score 
of 5 to 22.16 Because the baseline outcome distribution is less 
favorable for patients with an LVO, the same relative treat-
ment effect will give a smaller absolute effect in LVO stroke. 
The precise benefit of IVT before EVT is still uncertain be-
cause the available studies are flawed by confounding by indi-
cation.24,25 The results of ongoing randomized controlled trials 
comparing EVT and EVT with prior IVT have to provide 
more insight on this matter.
Outcome of stroke mimics, such as migraine, epilepsy, 
and conversion disorder, were considered to be independent 
of time since there are no time-dependent treatment options 
that would require transportation to the nearest hospital. 
Patients with an intracerebral hemorrhage might benefit from 
transportation to a specialized center, but there is currently in-
sufficient evidence to include the effect of rapid treatment in 
our model. Recent studies showed that EVT can be effective 
in a subgroup of stroke patients presenting between 6 and 24 
hours after onset.26,27 Other factors might be important to op-
timize triage of these patients and our results, therefore, only 
apply to patients presenting within 6 hours. Furthermore, we 
did not include costs in our model. Because the outcome was 
measured based on functional outcome, we were only able to 
model harm due to delayed treatment. Inconvenience of un-
necessary transportations for patients and their relatives, as 
well as inefficient resource utilization, was not integrated in 
the model. It is likely that unnecessary transportation to an 
intervention center will cause crowding at the emergency 
department, which might have financial consequences and a 
negative effect on the in-hospital workflow. It is, therefore, 
important to further explore the cost-effectiveness of different 
prehospital triage strategies.
Figure 2. The optimal transportation strategy based on the likelihood of 
large vessel occlusion. Primary stroke center: the nearest nonendovascu-
lar-capable stroke center; intervention center: the nearest endovascular-
capable stroke center. A, Represents the base case scenario (primary 
stroke center at 20 min and intervention center at 45 min); (B) the urban 





 http://ahajournals.org by on April 23, 2019
318  Stroke  February 2019
We constructed a decision model that predicts the optimal 
strategy based on individual patient characteristics and that can 
easily be adjusted for differences in geographic location or in-
hospital workflow characteristics. Our online tool forms the 
basis of personalized prehospital triage of suspected ischemic 
stroke patients. Clinicians and researchers can plug in the spe-
cific characteristics of their own region into this tool to guide 
local prehospital triage policies. Although a fixed threshold the 
likelihood of LVO might be suitable for triage in urbanized re-
gions with small distances between centers, our model showed 
that a higher threshold should likely be considered in more re-
mote areas. After more extensive validation of the prehospital 
stroke scales, the tool can be used to combine the individual’s 
likelihood of LVO with estimated driving and local workflow 
times to improve prehospital triage decisions on a case-by-case 
basis. Future integration with a GPS-controlled navigation ap-
plication will further facilitate personalized triage based on 
real-time information about driving and local workflow times.
Conclusions
The preferred prehospital transportation strategy for suspected 
stroke patients depends mainly on the likelihood of LVO, driv-
ing times, and in-hospital workflow times. We constructed a 
robust model that combines these characteristics and can be 
used to personalize prehospital triage, especially in more re-
mote areas. 
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